Article

Genetic research in flies reveals regulatory pathway similarities

The transcriptional regulatory pathways of invertebrate animals and vertebrate animals are comparable when it comes to lens formation, according to Tiffany Cook, PhD, who spoke about research in flies during a symposium about innovative strategies for eye development and regeneration in non-mammalian models.

The transcriptional regulatory pathways of invertebrate animals and vertebrate animals are comparable when itcomes to lens formation, according to Tiffany Cook, PhD, who spoke about research in flies during a symposiumabout innovative strategies for eye development and regeneration in non-mammalian models.

The research she reported is among the first of its kind, said Dr. Cook, assistant professor, Department ofOphthalmology, University of Cincinnati. It is expected to lay the groundwork for additional genetic studiesthat will attempt to identify regulatory pathways needed for the development of normal lenses as part of theundertaking to understand which parts of the pathways are negatively affected in those with congenital andage-related cataract.

Through their research with the fruit fly Drosophila melanogaster, Dr. Cook and colleagues believe thatthe Prospero protein and the PAX6 gene are necessary for some but not all cone cell development, that each has asecondary effect on primary pigment cell development, and that both seem to interact genetically to controlcornea/lens development. The question of whether lens development is evolutionarily conserved is an open one,she said.

"What we're learning in the fly eye . . . may have a significant impact on our understanding of how thesestructures are formed in humans, too," Dr. Cook concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.